The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Trega Biosciences, Inc.

Trega Biosciences, Inc.
 PROFILE
When it comes to drug development, Trega Biosciences would rather provide the cleaning supplies than do the dirty work. Its iDiscovery technologies speed the discovery of new treatments by offering drug modeling programs and Trega's combinatorial chemistry libraries of potential drug candidates. One component of iDiscovery is IDEA, a computer model that predicts a drug's absorption, distribution, metabolism, and excretion properties to determine if it's worthy of being developed. Trega also develops drugs, but only through alliances; its partners include Novartis, which is working with the firm on new therapies for diabetes, obesity, and other conditions. LION Bioscience bought the company.

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 13.40
1-Yr. Sales Growth: 24.1%
Employees: 117
Revenue per employee: $114,529.91

 KEY PEOPLE
• Michael G. Grey
    CEO

 CONTACT INFO
9880 Campus Point Dr.
San Diego, CA 92121
US
Phone: 858-410-6500
Fax: 858-410-6501

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001